Collins Helen Louise (CIK 1701247) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Sell ELVN (2,599 shares), Sell ELVN (1,133 shares), Sell ELVN (1,268 shares), Buy ELVN (5,000 shares), Buy ELVN (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 2,599 | $114,018 |
| 2026-06-22 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 1,133 | $50,694 |
| 2026-06-22 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 1,268 | $54,305 |
| 2026-06-22 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-05-20 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-05-20 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 3,475 | $137,381 |
| 2026-05-20 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 1,302 | $52,402 |
| 2026-05-20 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 223 | $9,189 |
| 2026-04-21 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-04-21 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 140 | $6,413 |
| 2026-04-21 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 2,419 | $114,635 |
| 2026-04-21 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 2,441 | $117,303 |
| 2026-03-27 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 40,000 | $99,200 |
| 2026-03-27 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 40,000 | $1.4M |
| 2026-03-19 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-03-19 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 5,000 | $138,800 |
| 2026-03-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 29,871 | $74,080 |
| 2026-03-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 29,871 | $896,727 |
| 2026-03-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 10,129 | $25,120 |
| 2026-03-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 10,129 | $305,795 |
| 2026-02-19 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 45,000 | $111,600 |
| 2026-02-19 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Sell | 45,000 | $1.2M |
| 2026-02-17 | Enliven Therapeutics, Inc. (ELVN) | CHIEF MEDICAL OFFICER | Buy | 25,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22